Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine - Top-Institutions - MDSpire

Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine

  • By

  • Elif Ilgaz Aydınlar

  • Pınar Yalınay Dikmen

  • Aysenur Sahin

  • Kerem Birısık

  • June 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Phoenix, Arizona

    Key Differentiators

    • Neurology
    • Headache Medicine

  • #2

    Thomas Jefferson University Hospitals
    Thomas Jefferson University Hospitals

    Philadelphia, Pennsylvania

    Key Differentiators

    • Neurology
    • Headache Medicine

Original Source(s)

Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine

  • by Elif Ilgaz Aydınlar, Pınar Yalınay Dikmen, Aysenur Sahin, Kerem Birısık

  • June 1, 2026

Related Content

Clinical profile of headache attributed to anxiety and depressive disorders: an observational study

Evaluating the Efficacy and Safety of Preventive Therapies for Vestibular Migraine: A Systematic Review and Network Meta-Analysis

Evaluation of the Safety and Effectiveness of Calcitonin Gene-Related Peptide Antagonists in Treating Cluster Headaches: A Systematic Review and Meta-Analysis